ENOXACIN - COMPARATIVE PHARMACOKINETICS AND TISSUE PENETRATION

被引：3

作者：

SORGEL, F ^{[1
]}

NABER, KG ^{[1
]}

METZ, R ^{[1
]}

MORGENROTH, A ^{[1
]}

机构：

[1] ELISABETH HOSP,UROL KLIN,D-8440 STRAUBING,FED REP GER

来源：

INFECTION | 1989年 / 17卷

关键词：

D O I：

10.1007/BF01643628

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：S14 / S18

页数：5

共 8 条

[1] INHIBITION OF ENOXACIN ABSORPTION BY ANTACIDS OR RANITIDINE [J].

GRASELA, TH ;

SCHENTAG, JJ ;

SEDMAN, AJ ;

WILTON, JH ;

THOMAS, DJ ;

SCHULTZ, RW ;

LEBSACK, ME ;

KINKEL, AW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (05) :615-617

[2]

LOEWE H, 1984, FORTSCHR ANTIMIKR AN, V3, P485

[3] REVIEW OF TISSUE PENETRATION AND CLINICAL EFFICACY OF ENOXACIN IN SKIN AND SKIN STRUCTURE INFECTIONS AND IN OSTEOMYELITIS [J].

PANKEY, GA .

CLINICAL PHARMACOKINETICS, 1989, 16 :46-51

[4]

POLK RE, 1988, CIPROFLOXACIN MAJOR, P28

[5]

SORGEL F, 1989, CLIN PHARMACOKINET, V16, P5

[6]

SORGEL F, 1987, FORTSCHR ANTIMIKROB, V6, P1907

[7]

SORGEL F, 1989, IN PRESS POSTGRADUAT

[8] CLINICAL OVERVIEW OF ENOXACIN [J].

ZINNER, SH .

CLINICAL PHARMACOKINETICS, 1989, 16 :59-64

← 1 →